Arkolith/Insider Trading/ACAD/Form 4

Owen Adams Catherine

Chief Executive Officer, DirectorACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Mar 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$250K
Net Open-Market Flow
-$250K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2026Sell(S)12K$21.47$250K15K
Mar 24, 2026Option exercise(M)24K—$026K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)24K—$071K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816838-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML